QuantX Biosciences

QuantX Biosciences is a private pharmaceutical company advancing the development of orally available small-molecule drugs through a computation-driven drug discovery platform. The company integrates physics-based modeling, statistical methods, and computational chemistry to rapidly design and optimize drug candidates targeting clinically validated pathways. QuantX focuses on building a differentiated therapeutic pipeline for immune-mediated and inflammatory diseases, aiming to enhance development efficiency and success rates. QuantX Biosciences, headquartered in Princeton, New Jersey, is supported by leading life science investors and a team with deep expertise in drug discovery and development.